Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...

Aware Infrastructure (PAI) to support generative AI development while enforcing privacy across complex data flows. Using ...

Aimee Picchi is the associate managing editor for CBS MoneyWatch, where she covers business and personal finance. She previously worked at Bloomberg News and has written for national news outlets ...

The structurally similar cytokines IL-2 and IL-15, and their shared beta subunit CD122, are keeping developers busy across a range of indications. Though some scientific confusion has plagued the ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...

The company that will revolutionize the way Americans shop on the internet through an intelligent system powered by “artificial intelligence” ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Christopher Mims is a columnist who writes about technology for The Wall Street Journal's tech bureau in San Francisco. The subjects of his columns vary widely from one week to the next. He has ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...